Kash Patel Becomes the Focus of Media Analysis They Consistently Get Wrong
The Deplorable Treatment of Afghan Women Is a Glimpse Into Our Future
In Record Time, Voters Are Regretting Electing Socialist Mamdani
Steven Spielberg Flees California Before Its Billionaire Wealth Tax Fleeces Him
Oklahoma Bill Would Mandate Gun Safety Training in Public Schools
Here Is the Silver Lining to the Supreme Court's Tariff Ruling
CA Bends the Knee, Newsom Will Now Mandate English Proficiency Tests for Truck...
Guatemalan Citizen Admits Using Stolen Identity to Obtain Custody of Teen Migrant
Oregon-Based Utility PacifiCorp Settles for $575M Over Six Devastating Wildfires
Armed Man Rammed Substation Near Las Vegas in Apparent Terror Plot Before Committing...
DOJ Moves to Strip U.S. Citizenship From Former North Miami Mayor Over Immigration...
DOJ Probes Three Michigan School Districts That Allegedly Teach Gender Ideology
5th Circuit Vacates Ruling That Blocked Louisiana's Mandate to Display 10 Commandments in...
Kansas Engineer Gets 29 Months for $1.2M Kickback Scheme on Nuclear Weapons Projects
DOJ Files Antitrust Lawsuit Against Ohio Healthcare Company
Tipsheet

Two Countries Just Announced They're Halting Use of Moderna Vaccine for Younger Age Groups

Two Countries Just Announced They're Halting Use of Moderna Vaccine for Younger Age Groups
AP Photo/Rogelio V. Solis

An unpublished Nordic study prompted Sweden and Denmark on Wednesday to announce a pause on the use of the Moderna vaccine in younger age groups.  

The study, which hasn’t been reviewed yet by the European Medicines Agency, raised concern over the risk of myocarditis and pericarditis in this demographic.

Advertisement

While the risk is small, "the connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose," the Swedish health agency said in a statement, Reuters reports. 

According to the agency, the risk was also more prevalent among young men and boys.

Denmark made the same “precautionary” call, though the Pfizer/BioNTech vaccine was already the primary option for those aged 12-17 in the country. 

"In the preliminary data ... there is a suspicion of an increased risk of heart inflammation, when vaccinated with Moderna," the Danish Health Authority said in a statement.

Both countries are now recommending the Pfizer jab for minors, which the EMA approved for use in May. Moderna’s Spikevax had been given the green light in July.

Advertisement

Related:

COVID-19 SWEDEN

In June, the U.S. FDA said it was adding a warning to both Pfizer and Moderna vaccines after a CDC advisory panel said data suggested a "likely association" between the vaccines and rare cases of myocarditis in adolescents and young adults. Despite the warning, doctors and researchers say they still strongly recommend that all Americans 12 and older get vaccinated, noting that the heart problems are uncommon and in most cases very mild.   

Two separate vaccine studies subsequently concluded, however, that COVID-19 itself poses a higher risk of symptoms, including heart inflammation, than the vaccines.  (CBS)

In the United States, only the Pfizer/BioNTech vaccine is authorized for use in minors. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement